NCT05576948

Brief Summary

The study will describe the natural history of cerebral palsy (CP) as children develop over the first 2 years of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
16mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Sep 2022Sep 2027

Study Start

First participant enrolled

September 8, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 5, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2027

Last Updated

September 25, 2025

Status Verified

September 1, 2025

Enrollment Period

4 years

First QC Date

October 5, 2022

Last Update Submit

September 22, 2025

Conditions

Outcome Measures

Primary Outcomes (14)

  • Change in Motor skills

    Peabody: Gross and Fine motor skills

    3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Speech and Language skills

    Bayley Scales of Infant and Toddler Development

    6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Cognitive skills

    Bayley Scales of Infant and Toddler Development

    6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Neurologic assessment

    Hammersmith Infant Neurological Examination

    3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Musculoskeletal assessment

    Modified Tardieu Scale

    3 months, 6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Musculoskeletal assessment

    Australian Spasticity Assessment Scale

    9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Musculoskeletal assessment

    Hip X-ray

    18 months, 24 months corrected age

  • Change in Vision

    Previas

    6 months, 9 months, 12 months, 18 months, 24 months (corrected age)

  • Vision

    Ricci

    3 months corrected age

  • Change in Sleep

    Sleep disturbances Scale for Children

    9 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Feeding skills

    Dysphagia Disorder Survey

    12 months, 18 months, 24 months (corrected age)

  • Change in Self Care

    Pediatric Evaluation of Disability Inventory Computerized Assessment Test

    6 months, 12 months, 18 months, 24 months (corrected age)

  • Change in Adaptive Behavior

    Infant Toddler Social Emotional Assessment

    12 months, 18 months, 24 months (corrected age)

  • Change in Parent Well Being

    Depression, Anxiety and Stress Scale

    12 months, 18 months, 24 months (corrected age)

Study Arms (1)

Children with or at high risk of CP

Infants with a diagnosis of CP OR at high risk of CP as per the international Clinical Practice Guideline for early diagnosis of CP. In order to develop prognostic curves for motor function a minimum of 3 data points are required per participant. For this reason infants will be included if they are 12 months or younger (corrected age) at the time of enrolment.

Eligibility Criteria

Age3 Months - 24 Months
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants with or at high-risk for CP

You may qualify if:

  • Infants will be included if they have a diagnosis of CP or "at high risk of CP" and under the age of 12 months.
  • Infants at high risk of CP as defined by any two (any combination) of the following:
  • Neuroimaging predictive of a motor disability including the involvement of 1 or more of the following structures: sensori-motor cortex, Basal Ganglia, Posterior Limb of the Internal Capsule, pyramids.
  • Trajectory of cramped synchronized general movements (GMs) on General Movement Assessment (GMA) OR absent fidgety GMs at fidgety age
  • Hammersmith Infant Neurological Exam (HINE) scores \<57 @ 3months or \<60 @ 6months or \<63 @9 months
  • Infants will also be included if they meet BOTH of the following criteria (even if infants have a HINE score greater than the cut off scores stated above:
  • i. Unilateral brain injury on neuroimaging (magnetic resonance imaging (MRI) or cranial ultrasound (CUS)) predictive of CP ii. Clinical signs of asymmetry

You may not qualify if:

  • Infants with progressive or neurodegenerative disorders or genetic disorders not associated with CP
  • Infants with other disability diagnoses e.g. Down Syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Karen L Harpster, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2022

First Posted

October 13, 2022

Study Start

September 8, 2022

Primary Completion (Estimated)

September 8, 2026

Study Completion (Estimated)

September 8, 2027

Last Updated

September 25, 2025

Record last verified: 2025-09

Locations